Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVitamin B12 injections are not a licensed weight-loss treatment in the UK, and there is no clinically established dosage or frequency for using them to reduce body weight. If you have come across clinics offering B12 shots as a fat-burning aid, it is worth knowing that this use sits outside the evidence base reviewed by the NHS or NICE. B12 injections do have a well-defined medical role, just not the one often advertised. This page explains what they are genuinely used for, why the weight-loss claim persists, and which injectable treatments actually have a UK licence for weight management — so you can make a properly informed decision about your options.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No clinical body in the UK (not the NHS, not NICE, not the MHRA) has established a dose or frequency of vitamin B12 injections for weight loss. The treatments are used medically to correct B12 deficiency, where the standard NHS schedule involves injections every two to three months once levels are stable, or more frequently during initial loading. That schedule is set by haematological need, not by weight-management goals.
The persistent claim that B12 shots accelerate metabolism or burn fat stems, in part, from a real but indirect connection. Severe B12 deficiency causes fatigue, weakness and sometimes low mood, symptoms that can reduce how active someone feels and how carefully they eat. Correcting a genuine deficiency can restore energy levels, which may then support healthier habits. But that is very different from B12 itself causing fat loss. Researchers have not found a direct effect on adipose tissue or appetite signalling from B12 supplementation in people who are not deficient.
If you are considering any injectable treatment for weight management, the overview of injectable weight-loss medicines on our site sets out which products hold a UK licence and what that means practically. B12 injections, whatever dose or frequency is claimed, are not among them.
A few reasons, none of them scientific. B12 injections are inexpensive, carry a low immediate risk profile, and are easy to administer, which makes them attractive to clinics looking to offer something injectable without the regulatory requirements that come with prescription-only medicines. Marketing often leans on the energy-and-metabolism angle, which sounds plausible even if the pathway does not hold up under scrutiny.
There is also a conflation effect: some private clinics bundle B12 injections with other compounds, including L-carnitine, in "fat-burning cocktails". If you have seen these advertised, our page on L-carnitine injection dosage for weight loss gives a similarly frank look at the evidence for that compound. In short, the co-administration of B12 with other substances does not rescue the absence of clinical evidence for the whole mix.
The NHS notes that people should be cautious about clinics offering injections for purposes not supported by UK clinical guidance. The NHS obesity treatment page is a useful reference for understanding which interventions have genuinely passed scrutiny.
Two injectable medicines hold a current UK marketing authorisation for weight management in adults: tirzepatide, sold as Mounjaro, and semaglutide, sold as Wegovy. Both work through gut-hormone pathways that regulate appetite and food intake, a mechanism with substantial clinical trial evidence behind it and ongoing MHRA monitoring. They are prescription-only medicines, meaning a qualified prescriber must assess you before any supply.
Tirzepatide starts at 2.5 mg weekly, which is the opening dose your prescriber will work from before adjusting upward based on how you respond. For semaglutide, the starting point is 0.25 mg weekly, titrated upward. The exact schedule for either is a clinical decision, not something to self-select from a comparison table. Our page on weight-loss injection dosages covers the licensed schedules in more detail.
If you are weighing up costs before starting, the cost of weight-loss injections page explains what a legitimate private prescription typically includes and why the headline price does not always reflect the full picture. NICE's appraisal of tirzepatide (TA1026) sets out the eligibility thresholds and the evidence review that underpinned the recommendation.
B12 deficiency is diagnosed with a blood test, usually requested by a GP when symptoms such as fatigue, pins and needles, or mouth soreness are present. People who follow a vegan or strict vegetarian diet, those with pernicious anaemia, and those who have had certain gut surgeries are at higher risk. If you suspect deficiency, a conversation with your GP is the right starting point, a blood test, not a course of injections from a private wellness clinic, is the diagnostic step.
One practical checking habit worth building: before booking any injectable treatment, spend thirty seconds searching the provider's name on the GPhC register at pharmacyregulation.org/registers. If the pharmacy is not listed, walk away. It takes less time than reading a menu.
Where B12 status is genuinely normal, additional B12 (by injection or otherwise) does not produce further metabolic benefit. The body excretes what it does not need. So if energy levels and metabolism are the goal, the evidence points firmly toward licensed appetite-regulating medicines, including semaglutide, where understanding how the Saxenda injection dose works for weight loss can help set realistic expectations, alongside lifestyle changes and addressing any real nutritional gaps, rather than B12 shots marketed without a clinical basis. Our clinical team takes that evidence-first approach with every consultation.
If you are ready to explore what is genuinely licensed for your situation, you are welcome to speak to our prescribers, it starts with a free consultation, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.